Tăng huyết áp kháng trị: Thực trạng và những tiếp cận điều trị mới
Tóm tắt
Tăng huyết áp kháng trị: Thực trạng và những tiếp cận điều trị mớiTài liệu tham khảo
1. Oparil, S. & Schmieder, R. E. New approaches in the treatment of hypertension. Circ. Res. 11 611074- 1095 (2015).
2. Sim, J. J. et al. Comparative risk of renal, cardiovascular, and mortality outcomes in controlled,
uncontrolled resistant, and nonresistant hypertension. Kidney Int. 88, 622-632 (2015).
3. Krum, H. et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373, 1275-1281 (2009).
4. Symplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 376, 1903-1909 (2010).
5. Bhatt, D. L. et al. A controlled trial of renal denervation for resistant hypertension. N. Engl. ]. Med.
, 1393-1401 (2014).
6. Bohm, M. et al. Registry on the effect of renal artery denervation in patients with uncontrolled hypertension. Hypertension 65, 766-774 (2015).
7. Williams, B. et al. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial. Lancet 386, 2059-2068 (2015).
8. Beaussier, H. et al. True antihypertensive efficacy of sequential nephron blockade in patients with resistant hypertension and confirmed medication adherence.]. Hypertens. 33, 2526-2533 (2015).
9. Lilach, O.L. and Stephen C.T. Hypertension in 2015: Resistant hypertention: impact and evolving treatment option. Nature Reviews Nephrology. 12,70 - 72n (2016)
